Table 2.

Evaluation of skin findings in obese patients and controls

	Study Group n (%)	Control Group n (%)	P value
Acanthosis nigricans	213 (47.3)	5 (3.3)	<0.001
Acrochordon	236 (52.4)	5 (3.3)	<0.001
Keratosis pilaris	78 (17.3)	2 (1.3)	<0.001
Gouty tophi	1 (0.2)	0	0.564
Hirsutismus	131 (29.1)	2 (1.3)	<0.001
Striae distensae	291 (64.7)	5 (3.3)	<0.001
Adiposis dolorosa	2 (0.4)	0	0.414
Lymphedema	26 (5.8)	0	0.003
Venous insufficiency	202 (44.9)	5 (3.3)	<0.001
Plantar hyperkeratosis	209 (46.4)	5 (3.3)	<0.001
Hyperhidrosis	81 (18.0)	1 (0.7)	<0.001
Intertrigo	62 (13.8)	0	<0.001
Pretibial myxedema	12 (2.7)	0	0.044
Cellulitis	135 (30)	0	<0.001
Viral infections	11 (2.4)	1 (0.7)	0.054
Varicous vein	185 (41.1)	6 (4)	<0.001
Hidradenitis suppurativa	4 (0.9)	0	0.247
Psoriasis	11 (2.4)	3 (2.0)	0.755
Atopic dermatitis	65 (14.4)	3 (2.0)	<0.001
Skin cancer	1 (0.2)	0	0.564
Contact dermatitis	18 (4)	10 (6.7)	0.180
Seborrheic dermatitis	44 (9.8)	7 (4.7)	0.052
Stasis dermatitis	14 (3.1)	0	0.029
Dishydrotic eczema	5 (1.1)	4 (2.7)	0.175
Tinea pedis	90 (20)	12 (8.0)	0.001
Onychomycosis	66 (14.7)	7 (4.7)	0.001
Tinea cruris	13 (2.9)	0	0.035
Tinea versicolor	4 (0.9)	4 (2.7)	0.100
Candidal infections	43 (9.6)	1 (0.7)	<0.001
Folliculitis	24 (5.3)	5 (3.3)	0.328
Furuncle	12 (2.7)	2 (1.3)	0.354
Carbuncle	2 (0.4)	0	0.414
Impetigo	1 (0.2)	0	0.564
Acute paronychia	0	1 (0.7)	0.083